CompletedPhase 2NCT00849147

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

Studying Burkitt lymphoma

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Medical College of Wisconsin
Principal Investigator: Mary Horowitz, MD, MS, MD
Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin
Intervention: Haploidentical Bone Marrow Transplantation(biological)
Enrollment: 55 enrolled
Eligibility: 1-70 years · All sexes
Timeline: 2008 – 2013

Study locations (17)

City of Hope National Medical Center, Duarte, California, United States
University of California San Diego Medical Center, La Jolla, California, United States
University of Florida College of Medicine (Shands), Gainesville, Florida, United States
Bone Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, Georgia, United States
Kapi'olani Medical Center for Women and Children, University of Hawaii, Honolulu, Hawaii, United States
University of Maryland, Greenbaum Cancer Center, Baltimore, Maryland, United States
Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center (SKCCC), Baltimore, Maryland, United States
DFCI, Massachusetts General Hospital, Boston, Massachusetts, United States
Karmanos Cancer Institute, Children's Hospital of Michigan, Detroit, Michigan, United States
Washington University, Barnes Jewish Hospital, St Louis, Missouri, United States
Oregon Health & Science University, Portland, Oregon, United States
Fox Chase, Temple University, Philadelphia, Pennsylvania, United States
Medical University of South Carolina, Charleston, South Carolina, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Baylor University Medical Center, Dallas, Texas, United States
+2 more locations on ClinicalTrials.gov

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · Blood and Marrow Transplant Clinical Trials Network · National Cancer Institute (NCI) · National Marrow Donor Program

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00849147 on ClinicalTrials.gov

Other trials for Burkitt lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Burkitt lymphoma →

← Back to all trials